Titre Étude observationnelle rétrospective pour évaluer l’imagerie et la gestion des patients atteints d’un cancer de la prostate résistant à la castration
Protocole ID AMGEN 20150126
ClinicalTrials.gov ID
Type(s) de cancer Prostate
Phase Autres
Institution CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL  
Ville Montréal
Investigateur(trice) principal(e) Dr Fred Saad
Coordonnateur(trice) Julie Frémond
 514-890-8000 poste 30831
Statut Actif en recrutement
Date d'activation 27-05-2016
Critètes d'éligibilité
  • Men diagnosed with castration-resistant prostate cancer, defined as a recorded PSA
  • value of ≥2 ng/mL despite ongoing androgen deprivation therapy (ADT)
  • Patient has completed at least one follow-up clinic visit subsequent to the development of castration-resistance (the date of this clinic visit defines the index date)
  • Age ≥18 years at index date
  • Patient can have prior or current evidence of detectable bone or visceral metastasis(es) and MUST have completed at least one additional follow-up visit subsequent to the identification of bone/visceral metastases and the patient’s chart contains details of this follow-up visit
Critètes d'exclusion
  • Patient had evidence of detectable bone or visceral metastasis(es) at index date
  • Patient has received investigational agent(s) or completed investigational procedures as part of a non-metastatic CRPC clinical study protocol